Bottom line
PAFIX vs TRGLX: the short answer
PAFIX (Global Macro Fund) and TRGLX (T. Rowe Price Global Stock Fund) are both mutual funds.
TRGLX is cheaper at 0.66% vs 0.79% — a difference of $13 a year per $10,000 invested.
Updated Nov 19, 2026
PAFIX vs TRGLX side by side
| PAFIX | TRGLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Principal | T. Rowe Price |
| Category | Global Stock | Global Stock |
| Expense ratio | 0.79% | 0.66% |
| Annual cost per $10k | $79 | $66 |
| 10-yr cost on $10k (prospectus) | — | $822 |
| Max front load | — | — |
| 12b-1 fee | — | 0% |
| 1-yr return | — | +17.0% |
| 5-yr return (annualized) | — | +12.3% |
| 10-yr return (annualized) | — | — |
| Best quarter | — | +31.1% |
| Worst quarter | — | −20.4% |
| Net assets (fund) | $170.8M | $8.3B |
| Number of holdings | 236 | 138 |
| Portfolio turnover | — | 172% |
| Returns as of | — | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
PAFIX and TRGLX share none of their top holdings.
PAFIX top 10
- Principal Funds, Inc - Government Money Market Fund - Class R-6 — 65.67%
- BlackRock Liquidity FedFund - Institutional Class — 20.09%
- N/a — 1.95%
- N/a — 0.95%
- N/a — 0.60%
- N/a — 0.44%
- N/a — 0.44%
- N/a — 0.33%
- N/a — 0.30%
- N/a — 0.27%
TRGLX top 10
- Nvidia Corp — 5.60%
- Taiwan Semiconductor Manufac — 3.53%
- Apple Inc — 3.23%
- Alphabet Inc Cl A — 2.90%
- Microsoft Corp — 2.50%
- Unitedhealth Group Inc — 2.39%
- Amazon.com Inc — 2.33%
- Asml Holding Nv — 2.24%
- Unilever Plc — 2.20%
- Broadcom Inc — 2.19%
FAQ
What is the difference between PAFIX and TRGLX?
PAFIX (Global Macro Fund) and TRGLX (T. Rowe Price Global Stock Fund) are both mutual funds. TRGLX is cheaper at 0.66% vs 0.79% — a difference of $13 a year per $10,000 invested.
Which is cheaper, PAFIX or TRGLX?
TRGLX has the lower expense ratio (0.66%).
Should I own both PAFIX and TRGLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.